Target intelligence / Profile preview

Human Albumin (ALB)

Target
ALB
Molecular classification
Plasma protein, Carrier protein, Albumin family
01

Overview

Human albumin is the most abundant protein in human plasma, synthesized primarily by the liver and accounting for approximately 50% of total plasma protein content (UniProt P02768). Its primary biological role is the maintenance of colloid osmotic pressure, which is essential for regulating the distribution of water between the intravascular and interstitial compartments (StatPearls, 2023). In clinical settings, albumin is utilized as a volume expander to treat conditions such as hypovolemia, hemorrhagic shock, and severe burns where fluid resuscitation is required. Beyond its hemodynamic functions, albumin acts as a versatile carrier protein, binding and transporting hormones, fatty acids, bile salts, and a wide array of therapeutic drugs (PubChem). The administration of exogenous albumin helps restore oncotic pressure in patients with hypoalbuminemia or significant fluid loss, thereby stabilizing blood pressure and reducing edema. It also possesses antioxidant properties and acts as a pH buffer within the blood. However, its use must be carefully monitored to avoid complications like hypervolemia or pulmonary edema, particularly in patients with underlying cardiac or renal dysfunction. Therapeutic albumin is typically derived from pooled human plasma and is processed to ensure viral safety.

Other names
Serum albuminHSAAlbumin (human)ALB
02

Mechanism of action

Human albumin increases the oncotic pressure of the plasma, drawing fluid from the interstitial space into the blood vessels to expand intravascular volume (StatPearls, 2023). It also functions as a transport protein, binding various endogenous and exogenous substances to regulate their free concentration in the blood (UniProt P02768).

03

Biological functions

Maintenance of colloid osmotic pressureTransport of hydrophobic moleculespH bufferingAntioxidant activityLigand binding
04

Disease associations

HypovolemiaShockHypoalbuminemiaCirrhosisNephrotic syndromeBurnsAcute respiratory distress syndrome (ARDS)
05

Safety considerations

Hypervolemia (fluid overload)Pulmonary edemaCongestive heart failure exacerbationHypocalcemiaAnaphylactic reactionsDilutional coagulopathy
06

Interacting drugs

Human Albumin

6 more in the full profile.

07

Biomarkers

Serum albumin concentrationColloid osmotic pressureMean arterial pressureCentral venous pressureHematocritUrine output

Beyond the preview

Go deeper on Human Albumin (ALB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Albumin (ALB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call